Sort
82,697 grants matching “vaccine development”
Adjuvant Development within the context of a vaccine to protect against B. pertussis for use in newborns.
$1,777,596Ofer Levy · Boston Children'S Hospital · N01 · FY2019 · AI
HIV Prevention Trials Network: Network Laboratory
$1,777,536Susan H Eshleman · Johns Hopkins University · UM1 · FY2013 · AI
Aging and Immunity to Infections
$1,777,452Trudeau Institute, Inc. · P01 · FY2003 · AG
UCLA Center for AIDS Research (CFAR)
$1,777,256Irvin S.y. Chen · University Of California Los Angeles · P30 · FY2007 · AI
Task X3: Manufacture and Characterization Services for Vaccines and Biologics
$1,776,910Advanced Bioscience Laboratories, Inc. · N01 · FY2012 · AI
Malaria Drug Resistance and Disease Virulence
$1,775,867Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Administrative Core
$1,775,381Philip Louis Felgner · University Of California-Irvine · U19 · FY2024 · AI
Nonhuman Primate Reagent Resource
$1,775,000Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · U24 · FY2023 · AI
Nonhuman Primate Reagent Resource
$1,775,000Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · U24 · FY2022 · AI
HIV VACCINE CLINICAL TRIALS UNIT
$1,774,800Vanderbilt University · U01 · FY2001 · AI
HIV VACCINE CLINICAL TRIAL UNIT AT SAINT LOUIS UNIVER
$1,774,648Saint Louis University · U01 · FY2004 · AI
The Genome Analysis Core
$1,774,477Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2019 · AI
Vaccine and Treatment Evaluation Units (VTEU)
$1,774,060Hana M El Sahli · Baylor College Of Medicine · UM1 · FY2020 · AI
Live Vector Vaccines Against Agents of Bioterror
$1,774,057James P. Nataro · University Of Maryland Baltimore · U19 · FY2007 · AI
Nonhuman Primate Reagent Resource
$1,774,044Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · U24 · FY2021 · AI
Orthopox immunization in patients with cancer or eczema
$1,773,663Dana-Farber Cancer Institute · U19 · FY2003 · AI
The AIDS Linked to the Intravenous Experience (ALIVE) Study
$1,772,707Gregory D Kirk · Johns Hopkins University · U01 · FY2015 · DA
The AIDS Linked to the Intravenous Experience (ALIVE) Study
$1,772,479Gregory D Kirk · Johns Hopkins University · U01 · FY2016 · DA
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$1,772,458Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Development Of New Approaches To Vaccines Against Neurotropic Flaviviruses
$1,771,622Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Immunotherapy with High Frequency, CEA Specific T Cells
$1,770,982Herbert Kim Lyerly · Duke University · P01 · FY2008 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,770,891Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Toward a Universal Influenza Virus Vaccine
$1,770,560Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2016 · AI
Immunotherapy with High Frequency, CEA Specific T Cells
$1,770,228Herbert Kim Lyerly · Duke University · P01 · FY2006 · CA
Task C11 NHP Model for Filovirus Vaccine: Efficacy and Immunogenecity Testing
$1,769,568Lovelace Biomedical & Environmental Research Institute · N01 · FY2012 · AI